Advertisement
The presentation will take place at 11:00 a.m. (Eastern) on Thursday,September 27, 2007 at the Grand Hyatt Hotel in New York City.
There will be a live webcast of the presentation from the conference. Thewebcast will be available through a link posted on the investor relationssection of the Pharmion website at http://investor.pharmion.com. The webcastwill be available for replay on Pharmion's website until at least November 30,2007. The presentation will also be available to download as a podcast.
Advertisement
About Pharmion
Pharmion is a biopharmaceutical company focused on acquiring, developingand commercializing innovative products for the treatment of hematology andoncology patients in the U.S., Europe and additional international markets.Pharmion has a number of products on the market including the world's firstapproved epigenetic drug, Vidaza(R), a DNA demethylating agent. For additionalinformation about Pharmion, please visit the company's website athttp://www.pharmion.com.
SOURCE Pharmion Corporation